A Phase III Double-Blind Randomized Trial Comparing Sertraline (Zoloft) And Hypericum Perforatum (St. John's Wort) In Cancer Patients With Mild To Moderate Depression.

Trial Profile

A Phase III Double-Blind Randomized Trial Comparing Sertraline (Zoloft) And Hypericum Perforatum (St. John's Wort) In Cancer Patients With Mild To Moderate Depression.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Dec 2016

At a glance

  • Drugs Sertraline (Primary) ; Hypericum
  • Indications Depressive disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Jul 2012 Actual patient number is 2 according to ClinicalTrials.gov.
    • 02 Jul 2012 Actual end date (Apr 2005) added as reported by ClinicalTrials.gov.
    • 02 Jul 2012 Actual initiation date changed from Aug 2003 to Mar 2004 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top